Literature DB >> 9742126

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

R Pinkas-Kramarski1, M Shelly, B C Guarino, L M Wang, L Lyass, I Alroy, M Alimandi, A Kuo, J D Moyer, S Lavi, M Eisenstein, B J Ratzkin, R Seger, S S Bacus, J H Pierce, G C Andrews, Y Yarden, M Alamandi.   

Abstract

The recently isolated second family of neuregulins, NRG2, shares its primary receptors, ErbB-3 and ErbB-4, and induction of mammary cell differentiation with NRG1 isoforms, suggesting functional redundancy of the two growth factor families. To address this possibility, we analyzed receptor specificity of NRGs by using an engineered cellular system. The activity of isoform-specific but partly overlapping patterns of specificities that collectively activate all eight ligand-stimulatable ErbB dimers was revealed. Specifically, NRG2-alpha [corrected], like NRG1-beta [corrected], emerges as a narrow-specificity ligand, whereas NRG2-beta [corrected] is a pan-ErbB ligand that binds with different affinities to all receptor combinations, including those containing ErbB-1, but excluding homodimers of ErbB-2. The latter protein, however, displayed cooperativity with the direct NRG receptors. Apparently, signaling by all NRGs is funneled through the mitogen-activated protein kinase (MAPK). However, the duration and potency of MAPK activation depend on the identity of the stimulatory ligand-receptor ternary complex. We conclude that the NRG-ErbB network represents a complex and nonredundant machinery developed for fine-tuning of signal transduction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9742126      PMCID: PMC109195          DOI: 10.1128/MCB.18.10.6090

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  High-resolution solution structure of the EGF-like domain of heregulin-alpha.

Authors:  N E Jacobsen; N Abadi; M X Sliwkowski; D Reilly; N J Skelton; W J Fairbrother
Journal:  Biochemistry       Date:  1996-03-19       Impact factor: 3.162

Review 2.  Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis.

Authors:  S Burden; Y Yarden
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

Review 3.  The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions.

Authors:  I Alroy; Y Yarden
Journal:  FEBS Lett       Date:  1997-06-23       Impact factor: 4.124

4.  Bivalence of EGF-like ligands drives the ErbB signaling network.

Authors:  E Tzahar; R Pinkas-Kramarski; J D Moyer; L N Klapper; I Alroy; G Levkowitz; M Shelly; S Henis; M Eisenstein; B J Ratzkin; M Sela; G C Andrews; Y Yarden
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

5.  Calculation of electrostatic potentials in an enzyme active site.

Authors:  M K Gilson; B H Honig
Journal:  Nature       Date:  1987 Nov 5-11       Impact factor: 49.962

6.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

7.  The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.

Authors:  R Pinkas-Kramarski; A E Lenferink; S S Bacus; L Lyass; M L van de Poll; L N Klapper; E Tzahar; M Sela; E J van Zoelen; Y Yarden
Journal:  Oncogene       Date:  1998-03-12       Impact factor: 9.867

8.  Identification of residues of the epidermal growth factor receptor proximal to residue 45 of bound epidermal growth factor.

Authors:  A E Summerfield; A K Hudnall; T J Lukas; C A Guyer; J V Staros
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

9.  Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations.

Authors:  R Pinkas-Kramarski; M Shelly; S Glathe; B J Ratzkin; Y Yarden
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

10.  Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.

Authors:  G Levkowitz; L N Klapper; E Tzahar; A Freywald; M Sela; Y Yarden
Journal:  Oncogene       Date:  1996-03-07       Impact factor: 9.867

View more
  30 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Authors:  L N Klapper; S Glathe; N Vaisman; N E Hynes; G C Andrews; M Sela; Y Yarden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

3.  Microanatomy of axon/glial signaling during Wallerian degeneration.

Authors:  Amy D Guertin; Dan P Zhang; Kimberley S Mak; John A Alberta; Haesun A Kim
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

4.  Heregulin-beta promotes matrix metalloproteinase-7 expression via HER2-mediated AP-1 activation in MCF-7 cells.

Authors:  Guogang Yuan; Lu Qian; Lun Song; Ming Shi; Dan Li; Ming Yu; Meiru Hu; Beifen Shen; Ning Guo
Journal:  Mol Cell Biochem       Date:  2008-07-04       Impact factor: 3.396

Review 5.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

6.  The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development.

Authors:  Richard Chan; William R Hardy; Michael A Laing; Sarah E Hardy; William J Muller
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

7.  Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2.

Authors:  Azucena Esparís-Ogando; Elena Díaz-Rodríguez; Juan Carlos Montero; Laura Yuste; Piero Crespo; Atanasio Pandiella
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

8.  Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

Authors:  C I Sartor; H Zhou; E Kozlowska; K Guttridge; E Kawata; L Caskey; J Harrelson; N Hynes; S Ethier; B Calvo; H S Earp
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

9.  ErbB4 promotes cyclooxygenase-2 expression and cell survival in colon epithelial cells.

Authors:  Mark R Frey; Valda C Hilliard; Matthew T Mullane; D Brent Polk
Journal:  Lab Invest       Date:  2010-06-28       Impact factor: 5.662

Review 10.  The ERBB3 receptor in cancer and cancer gene therapy.

Authors:  G Sithanandam; L M Anderson
Journal:  Cancer Gene Ther       Date:  2008-04-11       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.